The clinical significance of circulating tumour cells in breast cancer and colorectal cancer patients

Anticancer Research

Volumn 27, Issue 3 A, 2007, Pages 1337-1341

  Hauch, Siegfried ^a   Zimmermann, Silke ^a   Lankiewicz, Silke ^a   Zieglschmid, Veit ^a   Böcher, Oliver ^b   Albert, Winfried Hans ^a  

^a AdnaGen AG   (Germany)

^b Prionics AG   (Switzerland)

Author keywords

Breast cancer; Circulating tumour cells in blood (CTC); Clinical significance; Colorectal cancer; Disseminated tumor cells in bone marrow (DTC); Immunomagnetic enrichment; Peripheral blood

Indexed keywords

ANTHRACYCLINE; CARCINOEMBRYONIC ANTIGEN; CETUXIMAB; CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; EPITHELIAL CELL ADHESION MOLECULE; ESTROGEN RECEPTOR; MUCIN 1; PACLITAXEL; PROGESTERONE RECEPTOR; TRASTUZUMAB;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RELAPSE; CANCER STAGING; CELL MIGRATION; COLORECTAL CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION PROFILING; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR CELL;

BONE NEOPLASMS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; NEOPLASM CIRCULATING CELLS; NEOPLASM STAGING; PALLIATIVE CARE; RADIOTHERAPY, ADJUVANT; RNA, MESSENGER;

EID: 34249291981     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Solomayer EF, Becker S, Pergola-Becker G, Bachmann R, Kramer B, Vogel U, Neubauer H, Wallwiener D, Huober J and Fehm TN: Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients. Breast Cancer Res Treat 98: 179-184, 2006.
2. Braun S, Kentenich C, Janni W, Hepp F, de Waal J, Willgeroth F, Sommer H and Pantel K: Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. J Clin Oncol 18: 80-86, 2000.
3. Smerage JB and Hayes DF: The measurement and therapeutic implications of circulating tumour cells in breast cancer. Br J Cancer 94: 8-12, 2006.
4. Patel H, Le Marer N, Wharton RQ, Khan ZA, Araia R, Glover C, Henry MM and Allen-Mersh TG: Clearance of circulating tumor cells after excision of primary colorectal cancer. Ann Surg 235: 226-231, 2002.
5. Stathopoulou A, Vlachonikolis I, Mavroudis D, Perraki M, Kouroussis C, Apostolaki S, Malamos N, Kakolyris S, Kotsakis A, Xenidis N, Reppa D and Georgoulias V: Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J Clin Oncol 20: 3404-3412, 2002.
6. Xenidis N, Vlachonikolis I, Mavroudis D, Perraki M, Stathopoulou A, Malamos N, Kouroussis C, Kakolyris S, Apostolaki S, Vardakis N, Lianidou E and Georgoulias V: Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer. Ann Oncol 14: 849-855, 2003.
7. Giatromanolaki A, Koukourakis MI, Kakolyris S, Mavroudis D, Kouroussis C, Mavroudi C, Perraki M, Sivridis E and Georgoulias V: Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse. Int J Cancer 108: 620-627, 2004.
8. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW and Hayes DF: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351: 781-791, 2004.
9. Chelly J, Concordet JP, Kaplan JC and Kahn A: Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci USA 86: 2617-2621, 1989.
10. Zieglschmid V, Hollmann C, Gutierrez B, Albert W, Strothoff D, Gross E and Böcher O: Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells. Anticancer Res 25: 1803-1810, 2005.
11. Demel U, Tilz GP, Foeldes-Papp Z, Gutierrez B, Albert WH and Böcher O: Detection of tumour cells in the peripheral blood of patients with breast cancer. Development of a new sensitive and specific immunomolecular assay. J Exp Clin Cancer Res 23: 465-468, 2004.
12. Lankiewicz S, Gutierrez Rivero B and Bocher O: Quantitative real-time RT-PCR of disseminated tumor cells in combination with immunomagnetic cell enrichment. Mol Biotechnol 34: 15-28, 2006.
13. Perey L, Benhattar J, Peters R, Jaunin P and Leyvraz S: High tumour contamination of leukaphereses in patients with small cell carcinoma of the lung: a comparison of immunocytochemistry and RT-PCR. Br J Cancer 85: 1713-1721, 2001.
14. Meng S, Tripathy D, Shete S, Ashfaq R, Haley B, Perkins S, Beitsch P, Khan A, Euhus D, Osborne C, Frenkel E, Hoover S, Leitch M, Clifford E, Vitetta E, Morrison L, Herlyn D, Terstappen LW, Fleming T, Fehm T, Tucker T, Lane N, Wang J and Uhr J: HER-2 gene amplification can be acquired as breast cancer progresses. Proc Natl Acad Sci USA 101: 9393-9398, 2004.
15. O'Hara SM, Moreno JG, Zweitzig DR, Gross S, Gomella LG and Terstappen LW: Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer. Clin Chem 50: 826-835, 2004.
16. Hayes DF, Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Miller MC, Matera J, Allard WJ, Doyle GV and Terstappen LW: Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res 12: 4218-4224, 2006.
17. Hayes DF, Walker TM, Singh B, Vitetta ES, Uhr JW, Gross S, Rao C, Doyle GV and Terstappen LW: Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer. Int J Oncol 21: 1111-1117, 2002.
18. Italiano A, Saint-Paul MC, Caroli-Bosc FX, Francois E, Bourgeon A, Benchimol D, Gugenheim J and Michiels JF: Epidermal growth factor receptor (EGFR) status in primary colorectal tumors correlates with EGFR expression in related metastatic sites: biological and clinical implications. Ann Oncol 16: 1503-1507, 2005.